Article info

Original research
Prevalence and clinical implications of germline pathogenic variants in cancer predisposing genes in young patients across sarcoma subtypes

Authors

  1. Correspondence to Dr Giovana Tardin Torrezan, Clinical and Functional Genomics Group, ACCamargo Cancer Center, Sao Paulo 01509-900, Brazil; giovana.torrezan{at}accamargo.org.br
View Full Text

Citation

Carvalho NDAD, Santiago KM, Maia JML, et al
Prevalence and clinical implications of germline pathogenic variants in cancer predisposing genes in young patients across sarcoma subtypes

Publication history

  • Received March 10, 2023
  • Accepted July 11, 2023
  • First published August 3, 2023.
Online issue publication 
December 21, 2023
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.